Ex parte FRIEDMAN et al. - Page 5




          Appeal No. 95-4914                                                          
          Application No. 08/036,116                                                  


          the examiner, when the effective filing date for subject                    
          matter claimed in a U.S. application is in issue, the foreign               
          application relied upon for priority under the above section                
          of the statute must be examined to determine, inter alia,                   
          whether it describes within the meaning of 35 U.S.C. § 112's                
          first paragraph, what is claimed in the U.S. application.  In               
          re Gosteli, 872 F.2d 1008, 1011, 10 USPQ2d 1614, 1616 (Fed.                 
          Cir. 1989).  Here, we agree with the examiner that the foreign              
          priority document in question does not describe (35 U.S.C. §                
          112, first paragraph) what is now being claimed in the present              
          application.                                                                
               Appealed claim 1 requires, inter alia, a droplet                       
          comprising "about 0.1 to 10% of a second component of an                    
          emulsifier", and appealed claim 5 specifies that the                        
          emulsifier is a phospholipid compound or a mixture of                       
          phospholids.  Even were we to agree that the disclosure in the              
          Israeli application at page 4, lines 11-14 describes a droplet              
          comprised of first, second and third components as in the                   
          present application, no descriptive support is present in the               
          Israeli application regarding the claimed relative proportion               
          ranges for the respective first, second, and third components.              
                                          5                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007